Evidence map›Paper›PMID 40343530›Full record

ArticleMolecular biology reports2025

Development of 30 microsatellite markers for genetic analysis of Atrina vexillum.

Thomas Guttierez, Clara Mouronvalle, Emilie Boissin, Serge Planes

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular biology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Thomas GuttierezPSL Research University, CNRS-EPHE-UPVD, UAR3278 CRIOBE, Perpignan, 66860, France. thomas.guttierez.sci@gmail.com.ORCID http://orcid.org/0000-0002-2932-4143
Clara MouronvallePSL Research University, CNRS-EPHE-UPVD, UAR3278 CRIOBE, Perpignan, 66860, France.
Emilie BoissinPSL Research University, CNRS-EPHE-UPVD, UAR3278 CRIOBE, Perpignan, 66860, France.ORCID http://orcid.org/0000-0002-4110-790X
Serge PlanesPSL Research University, CNRS-EPHE-UPVD, UAR3278 CRIOBE, Perpignan, 66860, France.ORCID http://orcid.org/0000-0002-5689-5371

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAtrina vexillum (Born, 1778) is a bivalve mollusk indigenous to the Indo-Pacific coastal regions. Despite being a species of high ecological and economic value, it remains largely understudied and estimates of population genetic diversity and structure are urgently needed. Microsatellite markers are useful for assessing population genetic structure due to their high polymorphism. This study aimed to develop 30 novel, highly polymorphic, microsatellite markers for A. vexillum. METHODS AND

resultsA total of 30 markers were optimized for reliable amplification. They were tested by multiplex PCR in 92 individuals sampled in Bora-Bora and Raiatea islands (French Polynesia). The number of alleles per polymorphic locus (n = 29/30) ranged from 3 to 18. Null alleles were suspected for 6 of the markers. The F

conclusionThese 30 microsatellite markers demonstrate high polymorphism and will be key in assessing the genetic diversity and structure of A. vexillum populations in French Polynesia. They are a step towards analyzing parentage and further understanding the population dynamics and establishing effective conservation measures for a species that is declining without clearly identified causes.

Indexed as

BivalviaMicrosatellite RepeatsAllelesAnimalsGenetic LociGenetics, PopulationGenetic VariationHeterozygoteMultiplex Polymerase Chain ReactionPolymorphism, GeneticPolynesiaAtrina vexillumBivalveConservationFlag penshellGenetic diversityMicrosatellite

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.